Devaki A Kelkar
Overview
Explore the profile of Devaki A Kelkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koppiker C, Kelkar D, Kulkarni M, Kadu S, Pai M, Dhar U, et al.
Front Oncol
. 2023 Sep;
13:1176609.
PMID: 37746279
Introduction: The essential goal of neoadjuvant chemotherapy (NACT) is to downstage the primary tumor making it amenable for breast conservation surgery (BCS). However, since the safety of this surgery is...
2.
Koppiker C, Joshi S, Mishra R, Kelkar D, Chigurupati P, Joshi A, et al.
Front Oncol
. 2023 May;
13:1131951.
PMID: 37124516
Introduction: The majority of breast cancer patients from India usually present with advanced disease, limiting the scope of breast conservation surgery. Therapeutic mammoplasty (TM), an oncoplastic technique that permits larger...
3.
Joshi S, Mishra R, Kulkarni M, Kelkar D, Harikrishnan K, Vaid P, et al.
JCO Glob Oncol
. 2023 Jan;
9:e2200176.
PMID: 36657087
On January 13th and 14th 2022, the Center for Translational Cancer Research organized the virtual third Indian Cancer Genome Atlas (ICGA) Conference 2022 "Biobanking to Omics - Collecting the Global...
4.
Vaid P, Puntambekar A, Jumle N, Banale R, Ansari D, Reddy R, et al.
Diagn Pathol
. 2022 Nov;
17(1):91.
PMID: 36411483
Objectives: Evaluation of tumor-infiltrating lymphocytes (TILs) distribution in an Indian cohort of breast cancer patients for its prognostic significance. Methods: A retrospective cohort of breast cancer patients from a single...
5.
Venkatasubramanian G, Kelkar D, Mandal S, Jolly M, Kulkarni M
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407556
Breast cancers are treated according to the ER/PR or HER2 expression and show better survival outcomes with targeted therapy. Triple-negative breast cancers (TNBCs) with a lack of expression of ER/PR...
6.
Busheri L, Nare S, Banale R, Bapat A, Nagarkar M, Vetale D, et al.
South Asian J Cancer
. 2021 Aug;
10(1):39-41.
PMID: 34430517
The report evaluates the effect of coronavirus disease (COVID-19) pandemic on breast cancer treatment and management at a single-surgeon cancer care unit in one of the hotspots of COVID-19 in...
7.
Busheri L, Dixit S, Nare S, Alhat R, Thomas G, Jagtap M, et al.
Cancer Treat Res Commun
. 2021 Jun;
28:100409.
PMID: 34098400
Background: A breast cancer biobank with retrospectively collected patient data and FFPE tissue samples was established in 2018 at Prashanti Cancer Care Mission, Pune, India. It runs a cancer care...
8.
Kulkarni A, Kelkar D, Parikh N, Shashidhara L, Koppiker C, Kulkarni M
JCO Glob Oncol
. 2020 Jul;
6:1052-1062.
PMID: 32639876
Purpose: Breast cancer is the most common cancer in women in India, with higher incidence rates of aggressive subtypes, such as triple-negative breast cancer (TNBC). Methods: A systematic review was...
9.
Kelkar D, Khushoo A, Yang Z, Skach W
J Biol Chem
. 2011 Dec;
287(4):2568-78.
PMID: 22128180
Protein folding in cells reflects a delicate interplay between biophysical properties of the nascent polypeptide, the vectorial nature and rate of translation, molecular crowding, and cellular biosynthetic machinery. To better...
10.
Kelkar D, Chaudhuri A, Haldar S, Chattopadhyay A
Eur Biophys J
. 2010 Apr;
39(10):1453-63.
PMID: 20372885
The relevance of partially ordered states of proteins (such as the molten globule state) in cellular processes is beginning to be understood. Bovine alpha-lactalbumin (BLA) assumes the molten globule state...